^
BIOMARKER:

MYD88 L265P

i
Other names: MYD88, MYD88 Innate Immune Signal Transduction Adaptor, Myeloid Differentiation Primary Response Protein MyD88, Myeloid Differentiation Primary Response Gene (88), Myeloid Differentiation Primary Response 88, Mutant Myeloid Differentiation Primary Response 88, MYD88D
Entrez ID:
Related biomarkers:
MYD88 L265P
Waldenstrom Macroglobulinemia
zanubrutinib
Sensitive: B - Late Trials
MYD88 L265P
Waldenstrom Macroglobulinemia
rituximab + ixazomib
Sensitive: C2 – Inclusion Criteria
MYD88 L265P
Lymphoma
ibrutinib
Sensitive: C2 – Inclusion Criteria
MYD88 L265P
Waldenstrom Macroglobulinemia
venetoclax
Sensitive: C3 – Early Trials
MYD88 L265P
Marginal Zone Lymphoma
ibrutinib
Sensitive: C3 – Early Trials
MYD88 L265P
Waldenstrom Macroglobulinemia
daratumumab
Sensitive: C3 – Early Trials
MYD88 L265P
Diffuse Large B Cell Lymphoma
rituximab
Resistant: C3 – Early Trials
MYD88 L265P
Waldenstrom Macroglobulinemia
X4P-001
Sensitive: C3 – Early Trials
MYD88 L265P
Waldenstrom Macroglobulinemia
ICP-022
Sensitive: C3 – Early Trials
MYD88 L265P
Multiple Myeloma
lenalidomide + bortezomib
Sensitive: C4 – Case Studies
MYD88 L265P
Diffuse Large B Cell Lymphoma
KT-413
Sensitive: D – Preclinical